Cargando…

p-STAT3 is a PDC-E2 interacting partner in human cholangiocytes and hepatocytes with potential pathobiological implications

The E2 component of the mitochondrial pyruvate dehydrogenase complex (PDC) is the key autoantigen in primary biliary cholangitis (PBC) and STAT3 is an inflammatory modulator that participates in the pathogenesis of many liver diseases. This study investigated whether PDC-E2 interacts with STAT3 in h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kilanczyk, Ewa, Banales, Jesus M., Jurewicz, Ewelina, Milkiewicz, Piotr, Milkiewicz, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569217/ https://www.ncbi.nlm.nih.gov/pubmed/34737337 http://dx.doi.org/10.1038/s41598-021-01060-5

Ejemplares similares

DHEA Protects Human Cholangiocytes and Hepatocytes against Apoptosis and Oxidative Stress
por: Kilanczyk, Ewa, et al.
Publicado: (2022)

Melatonin Protects Cholangiocytes from Oxidative Stress-Induced Proapoptotic and Proinflammatory Stimuli via miR-132 and miR-34
por: Ostrycharz, Ewa, et al.
Publicado: (2020)

Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155
por: Adamowicz, Monika, et al.
Publicado: (2022)

Effect of Low Testosterone Levels on the Expression of Proliferator-Activated Receptor Alpha in Female Patients with Primary Biliary Cholangitis
por: Kempińska-Podhorodecka, Agnieszka, et al.
Publicado: (2023)

The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2019)

ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study
por: Koziarska, Dorota, et al.
Publicado: (2013)

Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies
por: Milkiewicz, Malgorzata, et al.
Publicado: (2012)

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC
por: Kruk, Beata, et al.
Publicado: (2018)

Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis
por: Wasik, Urszula, et al.
Publicado: (2017)

Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2021)

A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients
por: Kruk, Beata, et al.
Publicado: (2022)

The Role of hsa-miR-125b-5p Interaction with S1P/Ceramide Axis in the Potential Development of Inflammation-Associated Colon Cancer in Primary Sclerosing Cholangitis
por: Abramczyk, Joanna, et al.
Publicado: (2023)

Variant adiponutrin confers genetic protection against cholestatic itch
por: Krawczyk, Marcin, et al.
Publicado: (2014)

TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary Cirrhosis
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2013)

Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease
por: Wunsch, Ewa, et al.
Publicado: (2015)

Polymorphisms of IL12RB2 May Affect the Natural History of Primary Biliary Cholangitis: A Single Centre Study
por: Wasik, Urszula, et al.
Publicado: (2017)

Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis
por: Wasik, Urszula, et al.
Publicado: (2020)

Atypical cholangiocytes derived from hepatocyte-cholangiocyte transdifferentiation mediated by COX-2: a kind of misguided liver regeneration
por: Lan, Tian, et al.
Publicado: (2023)

Vitamin D Receptor Polymorphisms Predispose to Primary Biliary Cirrhosis and Severity of the Disease in Polish Population
por: Kempińska-Podhorecka, Agnieszka, et al.
Publicado: (2012)

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2016)

Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis
por: Adamowicz, Monika, et al.
Publicado: (2022)

TRAF1 Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2012)

Vitamin-D Receptor-Gene Polymorphisms Affect Quality of Life in Patients with Autoimmune Liver Diseases
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2020)

IL‐8 induces transdifferentiation of mature hepatocytes toward the cholangiocyte phenotype
por: Sasaki, Tokio, et al.
Publicado: (2019)

Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases
por: Wunsch, Ewa, et al.
Publicado: (2016)

Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR
por: Wunsch, Ewa, et al.
Publicado: (2015)

Hepatocyte‐Specific β‐Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes
por: Russell, Jacquelyn O., et al.
Publicado: (2019)

Ursodeoxycholic Acid Influences the Expression of p27(kip1) but Not FoxO1 in Patients with Non-Cirrhotic Primary Biliary Cirrhosis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2014)

Cholangiocytes act as Facultative Liver Stem Cells during Impaired Hepatocyte Regeneration
por: Raven, Alexander, et al.
Publicado: (2017)

Dynamics of hepatocyte-cholangiocyte cell-fate decisions during liver development and regeneration
por: Sahoo, Sarthak, et al.
Publicado: (2022)

Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
por: Hernández, Alejandra, et al.
Publicado: (2020)

Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR)
por: Stachowska, Ewa, et al.
Publicado: (2016)

PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis
por: Lopens, Steffi, et al.
Publicado: (2022)

Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo
por: Tanimizu, Naoki, et al.
Publicado: (2021)

Successful Derivation of Hepatoblasts, Cholangiocytes and Hepatocytes from Simian Induced Pluripotent Stem Cells
por: Luce, Eleanor, et al.
Publicado: (2022)

The appeal of the PDC program
por: Wasow, Thomas
Publicado: (2013)

H19 Is Expressed in Hybrid Hepatocyte Nuclear Factor 4α(+) Periportal Hepatocytes but Not Cytokeratin 19(+) Cholangiocytes in Cholestatic Livers
por: Jiang, YanChao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1dj88u4ip1ssimc7cm40abc1ac